ONCOLYS BIOPHARMA INC revenue for the last year amounted to 63.00 M JPY, the most of which — 63.04 M JPY — came from its highest performing source at the moment, Drug Discovery, the year earlier bringing 976.18 M JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought ONCOLYS BIOPHARMA INC 35.00 M JPY, and the year before that — 950.39 M JPY.